Compare Rush Street Interactive Inc (RSI) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs BIO-TECHNE Corp — how do they compare? Rush Street Interactive Inc trades at $33.46 (market cap $3.55B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 3.1× Rush Street Interactive Inc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals.
| RSI | TECH | |
|---|---|---|
Market Cap | $3.55B | $11.16B |
Sector | Technology | Health |
52-Week High | $34.52 | $72.12 |
52-Week Low | $14.55 | $43.31 |
Enterprise Value | $3.23B | $11.24B |
Dividend Yield | — | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rush Street Interactive (RSI) trades at $34.52, up 6.22% over 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q1 2026 EPS of $0.14, beating expectations, and maintains strong revenue growth projections for 2026. Recent expansion into Alberta and positive analyst coverage highlight operational momentum amid a high valuation multiple.
Outlook remains positive with 77% analyst buy ratings and a consensus price target of $30.44, though the stock trades above target. Risks include elevated P/E of 95.59 and net margin pressure at 2.98%. Earnings on July 29, 2026, will be critical for validating growth trajectory amid competitive and regulatory headwinds.
Bio-Techne (TECH) trades at $71.64, down 0.67% today, near its 52-week high following Merck KGaA's $73 per share acquisition offer. The stock shows bullish technical signals with strong moving averages, though RSI indicates overbought conditions. Recent earnings have been mixed, with Q4 2025 beating expectations but Q1 2026 missing. The company maintains solid gross margins of 64.96% but faces declining net income margins, down to 6.01% in 2025 from 25.09% in 2023.
The outlook is heavily influenced by the pending acquisition, offering a clear exit near current levels. Risks include shareholder litigation over deal fairness and fundamental profitability pressures. With a high P/E of 103.03, the stock's upside appears capped without the deal, while the $73 bid provides a near-term floor. Investors should weigh acquisition completion probability against operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
